SCHEMBL17145114

SCHEMBL17145114

O=C(O)c1ccnc(CNCc2cn(Cc3ccc(F)cc3)c3ccc(F)cc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 5/20 0.46
▸ KDM5A P29375 4/20 0.46
▸ KDM4C Q9H3R0 3/20 0.46
▸ KDM4A O75164 2/20 0.46
▸ THRB P10828 1/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ ICMT O60725 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17145050 0.85 PDE4A (0.45) KDM5BKDM5AKDM4CKDM4AKMT2A
SCHEMBL8804492 0.72 YES1 (0.54) KMT2AMEN1POLBNPC1GAA
SCHEMBL28375908 0.70 KDM4C (0.49) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL8805633 0.68 YES1 (0.68) KMT2AMEN1POLBMAPT
SCHEMBL8805590 0.68 YES1 (0.55) KMT2AKDM4EICMTALDH1A1
SCHEMBL8805985 0.67 TP53 (0.57) KMT2AMEN1POLBALDH1A1TP53
SCHEMBL17544476 0.67 HSP90AA1 (0.43) KDM5BKDM5AKDM4CKDM4ARAB9A
SCHEMBL17544589 0.66 PPARA (0.38) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL17670484 0.66 HSP90AA1 (0.44) KDM5BKDM5AKDM4CKDM4ARAB9A
SCHEMBL17549883 0.66 HSP90AA1 (0.44) KDM5BKDM5AKDM4CKDM4ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US claimed
EP-3126345-A1 INHIBITORS OF HISTONE DEMETHYLASES Gilead Sciences, Inc. (US) 2017-02-08 — — EP claimed
WO-2015153498-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS, APS (DK) 2015-10-08 — — WO claimed
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES KDM1B, KDM3A, KDM1A KDM5B 33/4885KDM5A 23/4885KDM4C 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback